Filing Details

Accession Number:
0001596783-22-000109
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-26 20:15:22
Reporting Period:
2022-08-24
Accepted Time:
2022-08-26 20:15:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1596783 Catalent Inc. CTLT Pharmaceutical Preparations (2834) 208737688
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1939253 Manja Boerman C/O Catalent, Inc.
14 Schoolhouse Road
Somerset NJ 08873
Pres. Biomodalities Division No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-08-24 6,676 $0.00 19,936 No 4 A Direct
Common Stock Disposition 2022-08-25 3,296 $103.04 16,640 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. Received upon the achievement of the fiscal 2020-22 performance-based vesting criteria set forth in certain incentive compensation held by the reporting person under the Issuer's long-term incentive plan.
  2. Includes restricted stock units.
  3. Shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of performance share units received pursuant to the Issuer's long-term incentive plan. No shares were withheld by or surrendered to the Issuer.